VLS Valneva SE

Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022

Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022

VALNEVA

Declaration of shares and voting rights

Interim status at June 22, 2022

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment A

Declaration date: June 27, 2022

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**
 



117,351,857



 



    including:
  • 117,331,343 ordinary shares with a par value of €0.15 each; and
  • 20,514 preferred shares convertible into ordinary shares, with a par value of €0.15 each
139,934,631 Double voting rights granted on 50 ordinary shares



 



Capital increase through cash contributions



 



Sale of 40 shares with double voting rights
June 11, 2022



 



June 19, 2022 i



 



June 21, 2022
139,810,309

___________________________

i Management Board decisions of June 19, 2022. Clearance and settlement on June 22, 2022.

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

 

Attachment



EN
27/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

Olfa Taamallah ... (+3)
  • Olfa Taamallah
  • Roy Külter
  • Yan Derocles
Martial Descoutures
  • Martial Descoutures
Olfa Taamallah ... (+3)
  • Olfa Taamallah
  • Roy Külter
  • Yan Derocles
Martial Descoutures
  • Martial Descoutures
 PRESS RELEASE

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreeme...

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus Saint-Herblain, France, June 26, 2025 – , (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the marketing and distribution of Valneva’s three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva’s single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva’s Japanese Encephalitis vaccine IXIARO® and ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch